Interface nationale ANTIBIORÉSISTANCE
Accès Collaboratif privé
Accueil • Veille Scientifique • An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections

A Decrease font size. A Reset font size. A Increase font size.

An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections

ACS Cent. Sci. • 2022.08.10

Parker E.N., Cain B.C., Hajian B., et al.
Lire l'article